Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 21,783 shares at $456.39 ($10.1M) on 2025-11-13, disclosed to the SEC on 2025-11-13.
Scheduled sale ($10.1M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $456.39 | 200 | $91K | 0.9% |
| 2 | $458.16 | 1,063 | $487K | 4.8% |
| 3 | $458.16 | 1,063 | $487K | 4.8% |
| 4 | $461.36 | 1,040 | $480K | 4.7% |
| 5 | $461.36 | 1,040 | $480K | 4.7% |
| 6 | $463.32 | 979 |
| $454K |
| 4.5% |
| 7 | $463.32 | 979 | $454K | 4.5% |
| 8 | $464.19 | 1,979 | $919K | 9.1% |
| 9 | $464.19 | 1,979 | $919K | 9.1% |
| 10 | $465.37 | 776 | $361K | 3.6% |
| 11 | $465.37 | 776 | $361K | 3.6% |
| 12 | $466.24 | 884 | $412K | 4.1% |
| 13 | $466.24 | 884 | $412K | 4.1% |
| 14 | $467.37 | 1,992 | $931K | 9.2% |
| 15 | $467.37 | 1,992 | $931K | 9.2% |
| 16 | $468.48 | 2,070 | $970K | 9.6% |
| 17 | $468.48 | 2,070 | $970K | 9.6% |
| 18 | $469.09 | 17 | $8K | 0.1% |
| Total | $464.83 avg | 21,783 | $10.1M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-18 | $4.1M | — | Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |